Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction.
about
Creatine phosphokinase-MB (CPK-MB) and the diagnosis of myocardial infarctionEVALUATION OF FOUR DIFFERENT SERUM ENZYMES IN THE DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTIONAn historical approach to the diagnostic biomarkers of acute coronary syndromeThe apex cardiogram in left bundle-branch blockEnzyme assays in diseases of the heart and skeletal muscle.Laboratory diagnosis of patients with acute chest pain.Studies on isocitric and lactic dehydrogenases in experimental myocardial infarction.Serum beta-enolase in acute myocardial infarction.Association between serum free fatty acid levels and possible related factors in patients with type 2 diabetes mellitus and acute myocardial infarction.High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke.Uses and limitations of enzyme tests.Enzyme studies in myocardial infarctionTHE PLACE OF TRANSAMINASE IN THE DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION.Permeability studies in heat-induced injury of skeletal muscle using lanthanum as fine structural tracer.Present and future biochemical markers for detection of acute coronary syndrome.Serum hydroxybutyrate dehydrogenase (HBD) assays in the clinical laboratory.Impact of plasma transaminase levels on the peripheral blood glutamate levels and memory functions in healthy subjects.Quantitation of infarct size in man by means of plasma enzyme levels.Complications in 220 patients with cardiac dysrhythmias treated by phased direct current shock, and indications for electroconversion.Biochemical Markers of Myocardial Damage.Uncoupling of increased cellular oxidative stress and myocardial ischemia reperfusion injury by directed sarcolemma stabilization.Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin.Biomarkers of tissue injury.Hypoxic hepatitis.Alanine aminotransferase: a clinical and regulatory tool for detecting liver injury-past, present, and future.Current applications of biomarkers in cardiomyopathies.Elevated liver enzymes indicating a diagnosis of limb-girdle muscular dystrophyWhat role does the stress response have in congestive heart failure?Biochemical changes in local tissue injury.Serum enzymes.Problems posed by observations of serum enzyme changes in toxicology.Measurement of aminotransferases: Part 1. Aspartate aminotransferase.Clinical enzymology.Measurement of certain plasma and serum enzymes in the horse.Diagnostic accuracy of serum enzyme assays for myocardial infarction in a general hospital population.Serum creatine phosphokinase estimations in myocardial infarction.Serum glutamic oxalacetic transaminase levels in diphtheritic myocarditisSERUM ENZYME LEVELS IN THE DIAGNOSIS OF ISCHAEMIC HEART DISEASE.Progress in myocardial damage detection: new biochemical markers for clinicians.Experience with serum glutamic oxaloacetic transaminase.
P2860
Q24536274-80F18D14-2115-436D-B891-1369FE2DD4B7Q24563461-7A9E79FD-E908-43DE-AB10-4DB8E31472A0Q27014824-9A7E2D5E-974A-4F06-B8AC-CCFE6ACA5EE2Q30535510-A84E4E83-C211-4D69-8CC4-227FDDFEB09CQ33899245-B096654E-E5C7-4D24-A10E-7C3AEF137105Q33975363-EB416524-38B7-439F-9A7B-7CFE088ED480Q34102397-02AAE5FF-4FC7-4FAA-9265-9073E06FCF63Q34118350-A8CD621A-55FB-4056-8277-74C7FC4D73DAQ34537384-7176AC58-C91A-4745-9EBB-04CDCBDC1E51Q35088233-0C08BC65-30F0-4A16-8BB1-09BAE55AE4D3Q35154461-132A2F88-DB71-4B2C-9F71-1EE56F3C3F3EQ35798302-A6A8D3C4-0F8E-40AC-B6B1-89C702BC6CB2Q35813072-A22A31FD-69B2-43A5-A3CA-34A351A097C2Q36101347-C01C1509-0220-46A2-B058-629836ECF033Q36624223-9FFE25F1-46B8-4262-81DF-AAFA8B490C6CQ36634529-4325DD12-1737-489C-8A17-3A1C6ADC6E3DQ36713848-E32C04A0-7D57-4B20-AC78-0BFBD0CDDA07Q36790157-82EA734C-8C15-46AA-830F-6AD990977F24Q36931437-6AADE2C4-E5C9-4818-9A7D-C5D4C6E629A4Q37155174-BEE05F78-6707-47CA-9848-11730ED7612CQ37577025-D23428C7-FED5-48A7-83A0-FC47BA6F9A82Q37670587-AD4049F1-0E5D-4291-9066-0F279658DF8DQ37755053-7FC63736-B4B5-416B-8BE8-7CF6219A9635Q37958085-D29B5CDA-9846-4A46-8C00-1F7C96A2BA3BQ38032729-95A9EC61-55A3-4B6D-A761-C0098B38F266Q38536678-FC110054-BE97-44F7-88D0-1774B4BAEBAEQ38976928-CA73FA16-C261-4C04-AB17-B0791F312D2FQ39298369-395E8E48-9131-41F6-B6F0-E88004EBB985Q39867019-1F3A7F79-EFB5-488B-AD98-0E84AD27A22DQ40001956-0818DBEB-CE27-4177-94C0-023F2723DBD6Q40007400-E398FDFC-5EB0-4461-B5AB-9DB26C2E0032Q40196487-1A3AA529-969E-4BFE-89DB-5CC1D232AF2DQ40480324-63B0D325-52E6-4ECB-BCF6-7D999B99F1CAQ40558703-1B95ED97-C3DE-45DF-A3EA-72139DD2347AQ41114691-D7284569-1591-4FA2-B0F0-9660C25545CBQ41190291-B0BA8B1C-50D7-4560-BDD0-1CA5B44CD6EAQ41282335-A68264DD-CB34-4624-BDBA-6AD7E06D12ABQ41293444-837B184A-E76E-4194-B974-09A172D9E25FQ41367903-99EC579F-EA39-4573-B2CF-AE1EF630D884Q41760228-14F4C78C-7465-4BF3-B6EB-B993C396DDB3
P2860
Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction.
description
1954 nî lūn-bûn
@nan
1954 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1954 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1954年の論文
@ja
1954年論文
@yue
1954年論文
@zh-hant
1954年論文
@zh-hk
1954年論文
@zh-mo
1954年論文
@zh-tw
1954年论文
@wuu
name
Serum glutamic oxaloacetic tra ...... nsmural myocardial infarction.
@ast
Serum glutamic oxaloacetic tra ...... nsmural myocardial infarction.
@en
Serum glutamic oxaloacetic tra ...... nsmural myocardial infarction.
@nl
type
label
Serum glutamic oxaloacetic tra ...... nsmural myocardial infarction.
@ast
Serum glutamic oxaloacetic tra ...... nsmural myocardial infarction.
@en
Serum glutamic oxaloacetic tra ...... nsmural myocardial infarction.
@nl
prefLabel
Serum glutamic oxaloacetic tra ...... nsmural myocardial infarction.
@ast
Serum glutamic oxaloacetic tra ...... nsmural myocardial infarction.
@en
Serum glutamic oxaloacetic tra ...... nsmural myocardial infarction.
@nl
P2093
P1433
P1476
Serum glutamic oxaloacetic tra ...... nsmural myocardial infarction.
@en
P2093
P304
P356
10.1126/SCIENCE.120.3117.497
P407
P577
1954-09-01T00:00:00Z